4D pharma (DDDD) News Today → What President Biden's new law means for investors (From Stansberry Research) (Ad) Free DDDD Stock Alerts GBX 16.66 0.00 (0.00%) (As of 11/8/2022) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 1, 2024 | markets.businessinsider.com4D Molecular Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)February 7, 2024 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About 4D Molecular TherapeuticsFebruary 7, 2024 | msn.com4D Molecular Therapeutics up 3%, prices $300M equityFebruary 5, 2024 | marketwatch.com4D Molecular Shares Hit 52-Week High After 4D-150 Eye Treatment TrialFebruary 5, 2024 | realmoney.thestreet.comHow to Trade a Surging 4D Molecular TherapeuticsFebruary 5, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: 4D Molecular Therapeutics (FDMT), Boston Scientific (BSX)February 5, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Valeo Pharma (OtherVPHIF) and AbbVie (ABBV)January 30, 2024 | news.yahoo.comIndian pharma firm Dr Reddy's beats Q3 profit view on strong US, European businessesNovember 27, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Merus (MRUS), 4D Molecular Therapeutics (FDMT) and Inari Medical (NARI)November 11, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Xenon (XENE), Adverum Biotechnologies (ADVM) and 4D Molecular Therapeutics (FDMT)November 2, 2023 | markets.businessinsider.comPositive Clinical Trial Results and Future Prospects Reinforce Buy Rating for 4D Molecular Therapeutics: An Analysis by Geulah LivshitsJuly 11, 2023 | markets.businessinsider.comBMO Capital Sticks to Their Buy Rating for 4D Molecular Therapeutics (FDMT)July 5, 2023 | msn.com4D Molecular Poised For Success: FDA Discussion And Solid Position In Competitive Genetic Medicine Space, Says AnalystApril 28, 2023 | marketwatch.com4D Molecular Down 25% After Wet AMD Drug UpdateApril 27, 2023 | markets.businessinsider.comWhat's Going On With 4D Molecular Therapeutics Stock TodayMarch 24, 2023 | marketwatch.comMicrobiome Therapeutics Market Current Trends, Segmentation, Key Players and Analysis Till 2035February 14, 2023 | marketwatch.comPharmacy Management System Market Scenario 2023 to 2028: New Developments, Economic Situation and Growth ProjectionJanuary 20, 2023 | finance.yahoo.comHuman Microbiome Market Report (2022 to 2030) – Obiome, 4D Pharma, Vedanta Biosciences, Second Genome, Ferring PharmaceuticalsDecember 30, 2022 | thetimes.co.uk4D Pharma rescue by Armistice to face voteOctober 5, 2022 | finance.yahoo.com4D pharma plc (DDDD.L)September 26, 2022 | nasdaq.comThe past year for 4D Molecular Therapeutics (NASDAQ:FDMT) investors has not been profitableJune 30, 2022 | apnews.com4D pharma plc (“4D pharma”) Receives Notice of Delisting From NasdaqJune 25, 2022 | thetimes.co.ukWoodford stock pick 4D Pharma collapsesJune 24, 2022 | finance.yahoo.comUpdate on Suspension of TradingMay 27, 2022 | proactiveinvestors.com.au4D Pharma outlines phase II plans for promising cancer drug candidateMay 17, 2022 | fool.co.ukHere’s why the 4D Pharma (LON:DDDD) share price is surging todayMay 17, 2022 | finance.yahoo.com4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International ConferenceMay 17, 2022 | proactiveinvestors.com4D pharma conference poster underlines safety and potential efficacy of asthma drug candidateMarch 25, 2022 | msn.comSMALL CAP MOVERS: 4D Pharma jumps; Diurnal divesMarch 25, 2022 | msn.comSMALL CAP MOVERS: 4D Pharma jumps after positive results from cancer drug trial ; hormone firm Diurnal dives on need of further fundingMarch 25, 2022 | proactiveinvestors.com4d pharma 'another stepping stone' for 4D Pharma after company hitting primary efficacy targetMarch 23, 2022 | proactiveinvestors.com4D Pharma PLC soars after meeting endpoint earlyMarch 23, 2022 | proactiveinvestors.com4D Pharma soars after meeting endpoint earlyMarch 23, 2022 | finance.yahoo.comMidday Stock Movers: GameStop, 4D Pharma Rise; Adobe, Vicor SlideMarch 23, 2022 | finance.yahoo.com4D Pharma Shares Soar On MRx0518/Keytruda Combo Trial Data In Renal Cell CarcinomaMarch 23, 2022 | finance.yahoo.com4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab) for the Treatment of Renal Cell CarcinomaMarch 23, 2022 | proactiveinvestors.com4D pharma sees early success as phase I/II cancer trial hits its efficacy target earlyMarch 23, 2022 | proactiveinvestors.com.au4D pharma jumps as early success as phase I/II cancer trial hits its efficacy target earlyMarch 23, 2022 | proactiveinvestors.com4D pharma jumps on early success as phase I/II cancer trial hits its efficacy target earlyMarch 9, 2022 | proactiveinvestors.com4D pharma prepares the ground for potential US fundraiserFebruary 23, 2022 | finance.yahoo.com4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines SummitFebruary 22, 2022 | proactiveinvestors.com4D pharma receives US regulatory green light for phase I trial of Parkinson's disease candidatesFebruary 22, 2022 | proactiveinvestors.com4D pharma receives US regulatory green light for phase I trial of its Parkinson's disease candidatesFebruary 21, 2022 | finance.yahoo.com4D Pharma restates first-half earnings due to accounting changeJanuary 22, 2022 | finance.yahoo.comHow Much Of 4D pharma plc (LON:DDDD) Do Insiders Own?January 4, 2022 | proactiveinvestors.com4D pharma hires new CFOJanuary 3, 2022 | finance.yahoo.com4D pharma appoints John Doyle as Chief Financial OfficerNovember 10, 2021 | fool.co.uk4D Pharma shares have rocketed and I’m tempted to buy nowOctober 12, 2021 | finance.yahoo.com4D pharma to Participate in Jefferies Virtual Next Generation IBD Therapeutics SummitOctober 11, 2021 | markets.businessinsider.com4d Pharma PLC : Half-year Report Get 4D pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for DDDD and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. DDDD Media Mentions By Week DDDD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DDDD News Sentiment▼0.000.42▲Average Medical News Sentiment DDDD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DDDD Articles This Week▼00▲DDDD Articles Average Week Get 4D pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for DDDD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: C4X Discovery News OKYO Pharma News Hemogenyx Pharmaceuticals News Ondine Biomedical News Arecor Therapeutics News Oncimmune News OptiBiotix Health News Sareum News Synairgen News Destiny Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:DDDD) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyThe #1 Crypto for AIWeiss Ratings**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
